Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Garcia Arieta

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Drug Development and Industrial Pharmacy|February 11, 2014
Composition specification of teicoplanin based on its estimated relative bioavailabilityAntonio Boix-Montañes, Alfredo Garcia-Arieta
Pharmaceutical Development and Technology|April 18, 2015
About the equivalence between different batches of a glycopeptide drugAntonio Boix-Montañes, Alfredo Garcia-Arieta
Clinical Pharmacokinetics|October 13, 2009
Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalenceLaszlo Tothfalusi, Laszlo Endrenyi, Alfredo Garcia Arieta
Biopharmaceutics & Drug Disposition|July 21, 2012
In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofenYasuhiro Tsume, Peter Langguth, Alfredo Garcia-Arieta, et al.
Clinical and Translational Science|May 3, 2019
Overview of the European Medicines Agency's Experience With Biowaivers in Centralized ApplicationsInes Lenić, Kevin Blake, Alfredo Garcia-Arieta, et al.
The AAPS Journal|August 31, 2016
Assessment of the Regulatory Methods for the Comparison of Highly Variable Dissolution ProfilesVictor Mangas-Sanjuan, Sarin Colon-Useche, Isabel Gonzalez-Alvarez, et al.
Molecular Pharmaceutics|August 4, 2015
Agitation Rate and Time for Complete Dissolution in BCS Biowaivers Based on Investigation of a BCS Biowaiver for Dexketoprofen TabletsAlfredo Garcia-Arieta, John Gordon, Luther Gwaza, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 12, 2010
Computer simulations for bioequivalence trials: selection of analyte in BCS drugs with first-pass metabolism and two metabolic pathwaysCarmen Navarro-Fontestad, Isabel Gonzalez-Alvarez, Carlos Fernández-Teruel, et al.
Pharmaceutics|April 26, 2025
Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence AssessmentJavier Zarzoso-Foj, Marina Cuquerella-Gilabert, Matilde Merino-Sanjuan, et al.
Chirality|November 23, 2019
Effect of enantiomerism on the bioequivalence of a new ibuprofen 600-mg tablet formulation obtained by roller compactionAntonio Matji, Emilio Vargas, Luis Carvajal, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Drug Development and Industrial Pharmacy|February 11, 2014
Composition specification of teicoplanin based on its estimated relative bioavailabilityAntonio Boix-Montañes, Alfredo Garcia-Arieta
Pharmaceutical Development and Technology|April 18, 2015
About the equivalence between different batches of a glycopeptide drugAntonio Boix-Montañes, Alfredo Garcia-Arieta
Clinical Pharmacokinetics|October 13, 2009
Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalenceLaszlo Tothfalusi, Laszlo Endrenyi, Alfredo Garcia Arieta
Biopharmaceutics & Drug Disposition|July 21, 2012
In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofenYasuhiro Tsume, Peter Langguth, Alfredo Garcia-Arieta, et al.
Clinical and Translational Science|May 3, 2019
Overview of the European Medicines Agency's Experience With Biowaivers in Centralized ApplicationsInes Lenić, Kevin Blake, Alfredo Garcia-Arieta, et al.
The AAPS Journal|August 31, 2016
Assessment of the Regulatory Methods for the Comparison of Highly Variable Dissolution ProfilesVictor Mangas-Sanjuan, Sarin Colon-Useche, Isabel Gonzalez-Alvarez, et al.
Molecular Pharmaceutics|August 4, 2015
Agitation Rate and Time for Complete Dissolution in BCS Biowaivers Based on Investigation of a BCS Biowaiver for Dexketoprofen TabletsAlfredo Garcia-Arieta, John Gordon, Luther Gwaza, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 12, 2010
Computer simulations for bioequivalence trials: selection of analyte in BCS drugs with first-pass metabolism and two metabolic pathwaysCarmen Navarro-Fontestad, Isabel Gonzalez-Alvarez, Carlos Fernández-Teruel, et al.
Pharmaceutics|April 26, 2025
Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence AssessmentJavier Zarzoso-Foj, Marina Cuquerella-Gilabert, Matilde Merino-Sanjuan, et al.
Chirality|November 23, 2019
Effect of enantiomerism on the bioequivalence of a new ibuprofen 600-mg tablet formulation obtained by roller compactionAntonio Matji, Emilio Vargas, Luis Carvajal, et al.
Pageof 2